[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2640 followers Created: 2025-07-17 20:32:55 UTC $ELDN New findings from Eledon Pharmaceuticals' Phase 1b trial of Tegoprubart in kidney transplant patients will be shared at World Transplant Congress 2025. More Info: $XBI $IBB $XPH $PPH  XXX engagements  **Related Topics** [$pph](/topic/$pph) [$xph](/topic/$xph) [$ibb](/topic/$ibb) [$xbi](/topic/$xbi) [more info](/topic/more-info) [$eldn](/topic/$eldn) [Post Link](https://x.com/OzmosiHealth/status/1945944826559729743)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Ozmosi @OzmosiHealth on x 2640 followers
Created: 2025-07-17 20:32:55 UTC
$ELDN New findings from Eledon Pharmaceuticals' Phase 1b trial of Tegoprubart in kidney transplant patients will be shared at World Transplant Congress 2025.
More Info: $XBI $IBB $XPH $PPH
XXX engagements
/post/tweet::1945944826559729743